Levofloxacin in pharma franchise in Punjab

Levofloxacin in PCD pharma franchise in Chennai

Levofloxacin in top pharma company in Raipur

Levofloxacin in pcd pharma supplier in Madurai

Levofloxacin in phama franchise company in India
Levofloxacin in phama distributor in Jodhpur

Home/Products /levofloxacin-250mg-tablet

Lexoziff 250 Tablet

Composition : Levofloxacin (250mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹52/-

Lexoziff 250 Tablet is an effective broad-spectrum antibiotic that belongs to the fluoroquinolone class, specifically designed to treat a variety of bacterial infections. Levofloxacin works by inhibiting the activity of bacterial enzymes such as DNA gyrase and topoisomerase IV, which are essential for DNA replication and cell division. By interfering with these processes, Levofloxacin prevents the growth and reproduction of bacteria, making it effective against both Gram-positive and Gram-negative bacteria.

Lexoziff 250 is commonly prescribed for infections of the respiratory system, such as pneumonia, bronchitis, and sinusitis, as well as urinary tract infections, skin infections, and soft tissue infections. It is also utilized for treating acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) and infections in certain other organ systems. With its broad spectrum of activity, Lexoziff 250 is highly effective in managing infections that are resistant to other antibiotic treatments.

This medication is typically well tolerated and offers quick relief, allowing for better clinical outcomes in treating bacterial infections. The convenience of a once-daily dosage regimen further enhances patient adherence to the prescribed treatment course.

Read More

About the Product

Lexoziff 250 Tablet is an effective broad-spectrum antibiotic that belongs to the fluoroquinolone class, specifically designed to treat a variety of bacterial infections. Levofloxacin works by inhibiting the activity of bacterial enzymes such as DNA gyrase and topoisomerase IV, which are essential for DNA replication and cell division. By interfering with these processes, Levofloxacin prevents the growth and reproduction of bacteria, making it effective against both Gram-positive and Gram-negative bacteria.

Lexoziff 250 is commonly prescribed for infections of the respiratory system, such as pneumonia, bronchitis, and sinusitis, as well as urinary tract infections, skin infections, and soft tissue infections. It is also utilized for treating acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) and infections in certain other organ systems. With its broad spectrum of activity, Lexoziff 250 is highly effective in managing infections that are resistant to other antibiotic treatments.

This medication is typically well tolerated and offers quick relief, allowing for better clinical outcomes in treating bacterial infections. The convenience of a once-daily dosage regimen further enhances patient adherence to the prescribed treatment course.

Common side effects include nausea, diarrhea, headache, dizziness, and abdominal discomfort. Severe allergic reactions are rare but can occur.

Lexoziff 250 Tablet is indicated for the treatment of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and chronic obstructive pulmonary disease (COPD) exacerbations.

Do not use if allergic to Levofloxacin or any other fluoroquinolone antibiotics. Consult your doctor if pregnant, breastfeeding, or suffering from kidney or liver disease.

Store in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation